Santen Pharmaceutical Director of Finance Salaries in Boulder | Comparably
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
132

Santen Pharmaceutical Director of Finance Salaries in Boulder

The average Santen Pharmaceutical Director of Finance in Boulder earns an estimated $147,891 annually. Santen Pharmaceutical's Director of Finance compensation is $14,124 less than the US average for a Director of Finance.

In Boulder, The Finance Department at Santen Pharmaceutical earns $4,091 more on average than the Business Development Department.

Last updated 4 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$147,891
Average Compensation
$147,891
avg. base

Director of Finance Salaries at Santen Pharmaceutical

In Boulder, Directors of Finance earn $36,565 more than Accounting Managers.

Accounting Manager
$111k*
Financial Analyst
$92k*
Business Analyst
$88k*
Senior Accountant
$78k*
Accountant
$54k*
* estimated salary

Compensation at Santen Pharmaceutical by Department

In Boulder, The Finance Department averages $4,091 more than the Business Development Department, and $6,853 less than the Sales Department

Sales
$102,160 Avg. total comp.
+$7k
Finance
$95,307 Avg. total comp.
Business Development
$91,216 Avg. total comp.
-$4k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Santen Pharmaceutical reported making $169,182, while the average male Director of Finance at similar sized companies reported making $188,100.

Director of Finance Compensation by Ethnicity (All Companies)

The average Caucasian Director of Finance at companies similar size to Santen Pharmaceutical reported making $184,183, while the average Native American Director of Finance at similar sized companies reported making $30,000.

How Directors of Finance at Santen Pharmaceutical Rate Their Compensation

The majority of Directors of Finance at Santen Pharmaceutical believe they're not compensated fairly. 50% of Directors of Finance at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical

×
Rate your company